Literature DB >> 6359377

Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.

I Kallings, S Bengtsson, P Christensen, S E Holm, L Lind, M Kalin.   

Abstract

Isolates of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis were collected from five laboratories in different geographical areas in Sweden. Nine hundred and fortyfour strains were tested by the agar dilution method for susceptibility to seven oral antibiotics: phenoximethylpenicillin, ampicillin, cefaclor, erythromycin, doxycycline, trimethoprim-sulfamethoxazole and chloramphenicol. The H. influenzae and B. catarrhalis strains were also tested for beta-lactamase production. Of the H. influenzae strains, 8% were beta-lactamase-producing, while 35% of B. catarrhalis strains produced beta-lactamase. The latter value is higher than has earlier been reported in Sweden. Five S. pneumoniae strains showed decreased sensitivity to penicillin, and 9.5% of the S. pneumoniae strains showed a decreased sensitivity to one or more of the seven antibiotics tested. The S. pyogenes strains were sensitive to all the antibiotics tested with the exception of 4% of the strains, which showed a decreased sensitivity to doxycycline.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359377

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  14 in total

1.  The frequency of resistance to erythromycin in group A streptococci in Ankara.

Authors:  A E Kürekçi; M Baysallar; A Karaarslan; G Emekdaş; V Köseoğlu; R Akin; O Ozcan
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

2.  Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin).

Authors:  K Kanclerski; R Möllby
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

3.  In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

Authors:  S Alvarez; M Jones; S Holtsclaw-Berk; J Guarderas; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

4.  Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.

Authors:  C Betriu; A Sanchez; M Gomez; A Cruceyra; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

5.  Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.

Authors:  B A Brown; R J Wallace; C W Flanagan; R W Wilson; J I Luman; S D Redditt
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 6.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

7.  Beta-lactamase production in Branhamella catarrhalis isolated from lower respiratory tract secretions in Danish children: an increasing problem.

Authors:  T Ejlertsen; H C Schønheyder; E Thisted
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

8.  A one-year study of streptococcal infections and their complications among Ethiopian children.

Authors:  W Tewodros; L Muhe; E Daniel; C Schalén; G Kronvall
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

9.  Antibiotic therapy of meningitis caused by ampicillin-resistant Haemophilus influenzae in Denmark and Greenland 1981 to 1987.

Authors:  T Cordtz; O B Jepsen; M Arpi; P Hønberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

10.  In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.

Authors:  B O Liljequist; L Gezelius
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.